Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bertoni

Showing results (301-310 of 341) with videos related to

Pageof 35
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)M Ghielmini, S F Schmitz, K Bürki, et al.
International Journal of Cancer|November 14, 1997
Altered G1 phase regulation in osteosarcomaM S Benassi, L Molendini, G Gamberi, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 9, 1998
Prognostic relevance of C-myc gene expression in giant-cell tumor of boneG Gamberi, M S Benassi, T Böhling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2005
In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomasK Lacrima, A Valentini, C Lambertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamideG Bacci, A Briccoli, M Rocca, et al.
La Chirurgia Degli Organi Di Movimento|September 1, 1996
The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli InstituteG Bacci, S Ferrari, C Forni, et al.
Tumori|June 11, 1999
Minimal requirements in prostate cancer irradiation: a consensus document by the AIRO Lombardia Cooperative GroupR Valdagni, F Bertoni, A Bossi, et al.
International Journal of Oncology|January 26, 1999
Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcomaM Serra, D Maurici, K Scotlandi, et al.
Histology and Histopathology|March 17, 2004
Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcomaP Ragazzini, G Gamberi, L Pazzaglia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2001
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremityG Bacci, S Ferrari, A Tienghi, et al.
Pageof 35

Showing results (301-310 of 341) with videos related to

Sort By:
Pageof 35
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)M Ghielmini, S F Schmitz, K Bürki, et al.
International Journal of Cancer|November 14, 1997
Altered G1 phase regulation in osteosarcomaM S Benassi, L Molendini, G Gamberi, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 9, 1998
Prognostic relevance of C-myc gene expression in giant-cell tumor of boneG Gamberi, M S Benassi, T Böhling, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2005
In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomasK Lacrima, A Valentini, C Lambertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamideG Bacci, A Briccoli, M Rocca, et al.
La Chirurgia Degli Organi Di Movimento|September 1, 1996
The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli InstituteG Bacci, S Ferrari, C Forni, et al.
Tumori|June 11, 1999
Minimal requirements in prostate cancer irradiation: a consensus document by the AIRO Lombardia Cooperative GroupR Valdagni, F Bertoni, A Bossi, et al.
International Journal of Oncology|January 26, 1999
Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcomaM Serra, D Maurici, K Scotlandi, et al.
Histology and Histopathology|March 17, 2004
Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcomaP Ragazzini, G Gamberi, L Pazzaglia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2001
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremityG Bacci, S Ferrari, A Tienghi, et al.
Pageof 35